基本分析
透過季節調整季營收，判斷美股整體趨勢，但注意股價有時候領先基本面的數據，應搭配其他領先指標判斷。
基本資料
個股的基本資料，以及所屬的類股和產業。
公司介紹
業務介紹
格里福斯公司(Grifols, S.A.)從事治療產品(主要為血漿衍生物)的採購、製造、準備和銷售。該公司通過生物科學、醫院、診斷、生物供應和其他部門運營。
生物科學部門研究、開發、生產和銷售血漿衍生藥物和其他創新解決方案,以治療患有慢性、罕見、普遍和危及生命的疾病的患者。它提供免疫球蛋白、α1-抗胰蛋白酶、白蛋白、凝血因子和高免疫球蛋白。
醫院部門提供非生物製藥產品和醫療用品,包括臨床營養、靜脈療法和醫療器械。
診斷部門研究、開發、生產和商業化診斷產品,涵蓋從預防、篩查、診斷和預後到疾病和治療監測的整個醫療保健連續體,以服務專業人士。
生物供應部門提供生命科學研究、臨床試驗和製藥及診斷產品製造所需的生物材料。
其產品和服務被醫療服務提供者用於診斷和治療血友病、免疫缺陷、傳染病和其他醫療狀況的患者。
該公司為公共和私人客戶以及批發商、分銷商、集團採購組織、血庫、醫院和護理機構以及國家衛生系統提供服務。
格里福斯公司與蒙德拉貢(Mondragon)有技術合作協議。該公司成立於1940年,總部位於西班牙巴塞羅那。
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic division researches, develops, produces, and commercializes diagnostic products that span the healthcare continuumfrom prevention, screening, diagnosis, and prognosis to disease and treatment monitoringto serve professionals. The Bio Supplies division provides biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.
警語
1. 資料僅供參考，不做任何獲利保證及特定股票與點位推薦建議。
2. 資料並不完整，需要完整資料請至相關網站索取。
3. 任何股市數據分析皆存在倖存者偏差。
